Biogen Inc (BIIB)
234.46
+4.89
(+2.13%)
USD |
NASDAQ |
Dec 06, 12:58
Biogen Price: 234.46 for Dec. 6, 2023
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Dec 05, 2023 | 232.00 | 232.48 | 229.16 | 229.57 | 850828.0 |
| Dec 04, 2023 | 234.11 | 236.24 | 232.32 | 232.85 | 945656.0 |
| Dec 01, 2023 | 233.95 | 234.76 | 231.11 | 234.64 | 734994.0 |
| Nov 30, 2023 | 232.68 | 235.11 | 229.24 | 234.08 | 1.493M |
| Nov 29, 2023 | 228.00 | 234.06 | 227.42 | 232.06 | 1.464M |
| Nov 28, 2023 | 227.65 | 227.65 | 223.89 | 227.41 | 802301.0 |
| Nov 27, 2023 | 231.25 | 232.25 | 227.09 | 228.79 | 814921.0 |
| Nov 24, 2023 | 231.25 | 232.47 | 229.37 | 231.95 | 396390.0 |
| Nov 22, 2023 | 230.95 | 231.41 | 229.48 | 231.25 | 505525.0 |
| Nov 21, 2023 | 230.40 | 231.91 | 228.88 | 229.57 | 696129.0 |
| Nov 20, 2023 | 228.13 | 231.00 | 228.13 | 230.11 | 819628.0 |
| Nov 17, 2023 | 230.94 | 230.94 | 226.75 | 228.00 | 1.447M |
| Nov 16, 2023 | 231.22 | 232.88 | 227.85 | 229.46 | 790672.0 |
| Nov 15, 2023 | 224.43 | 231.66 | 223.17 | 229.63 | 1.346M |
| Nov 14, 2023 | 226.14 | 227.46 | 224.02 | 225.26 | 999913.0 |
| Nov 13, 2023 | 223.24 | 224.73 | 220.86 | 222.59 | 856352.0 |
| Nov 10, 2023 | 225.39 | 226.95 | 221.39 | 224.79 | 1.330M |
| Nov 09, 2023 | 231.97 | 232.11 | 222.59 | 224.65 | 1.578M |
| Nov 08, 2023 | 245.69 | 246.51 | 229.10 | 231.69 | 2.802M |
| Nov 07, 2023 | 246.60 | 248.39 | 241.52 | 245.61 | 1.483M |
| Nov 06, 2023 | 249.50 | 251.50 | 247.65 | 248.63 | 1.061M |
| Nov 03, 2023 | 244.20 | 251.51 | 243.66 | 249.50 | 992627.0 |
| Nov 02, 2023 | 239.60 | 242.50 | 237.38 | 241.86 | 802512.0 |
| Nov 01, 2023 | 238.56 | 241.06 | 235.10 | 239.62 | 841896.0 |
| Oct 31, 2023 | 236.69 | 239.00 | 236.07 | 237.54 | 681403.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
187.54
Minimum
May 09 2022
414.71
Maximum
Jun 10 2021
268.62
Average
270.43
Median
Nov 12 2021
Price Benchmarks
| Eli Lilly and Co | 590.01 |
| Gilead Sciences Inc | 79.19 |
| Ionis Pharmaceuticals Inc | 49.92 |
| Sage Therapeutics Inc | 20.80 |
| Vertex Pharmaceuticals Inc | 351.63 |
Price Related Metrics
| PE Ratio | 23.31 |
| PS Ratio | 3.407 |
| Price to Book Value | 2.346 |
| Price to Free Cash Flow | 33.18 |
| Earnings Yield | 4.29% |
| Market Cap | 33.97B |
| Operating PE Ratio | 17.90 |
| Normalized PE Ratio | 19.38 |